Pharma Stocks

Anuh Pharma Ltd Technical Momentum Shifts Amid Bearish Si…

Technical Trend Overview Recent analysis reveals that Anuh Pharma’s technical trend has deteriorated from mildly bearish to outright bearish. The…

Read More »

How Positive CAH Phase 2 Data And Palsonify Uptake At Crinetics Pharmaceuticals (CRNX) Has Changed Its Investment Story

Recently, Crinetics Pharmaceuticals reported encouraging Phase 2 data in congenital adrenal hyperplasia, showing that a meaningful share of patients in…

Read More »

Cipla and 4 Other Pharma Stocks Leading the Generic Medicine Segment to Watch Out For

Synopsis: Generic medicines are cost-effective versions of patented drugs that meet identical safety and efficacy standards. India leads the global…

Read More »

Stock Market News for Feb 21, 2026

3 news published. Stay ahead of the market with our list of today’s most important stock news and financial updates.…

Read More »

Under?the?Radar Pharma Giant US Investors Keep Missing

Otsuka just moved on new drug catalysts and pipeline updates—but most U.S. portfolios still ignore this $10bn+ Japan pharma name.…

Read More »

Dr. Reddy’s Stock Pops on US Launch Momentum: Buy the Breakout?

Dr. Reddy’s is quietly tightening its grip on the US generics market while the stock re-rates higher. Here’s what the…

Read More »

Deutsche Bank Upgrades Merck (MRK) to Buy, Sees “Clear Path” Beyond Keytruda Patent Cliff

Merck & Co., Inc. (NYSE:MRK) is included among the 16 Best Dividend Stocks with Rising Payouts. On February 13, Deutsche…

Read More »

Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026? – February 20, 2026

Key Takeaways Bristol Myers emerges as the stronger near-term pick over Merck. BMY’s new drugs, label expansions and $2B cost-savings…

Read More »

Mankind Pharma Ltd Stock Falls to 52-Week Low of Rs.2016

Stock Performance and Market Context On 20 Feb 2026, Mankind Pharma Ltd’s stock price fell to Rs.2016, the lowest level…

Read More »

Is Pfizer Stock the Only Big Pharma Name I’d Buy and Hold Through Any Market Crash?

Key Points Pfizer has reached a transition point following declines of some of its biggest blockbusters. The pharma giant is…

Read More »